Gregory R Jackson PhDChief Scientific Officer, MacuLogix, Inc., Hummelstown, PA
Gregory Jackson, PhD is an entrepreneurial scientist with clinical research expertise in the areas of age-related macular degeneration and diabetic retinopathy. He serves as Chief Scientific Officer for MacuLogix, Inc., a start-up medical diagnostic device company. He invented and commercialized the AdaptDx, diagnostic test and clinical research tool for age-related macular degeneration
Dr. Jackson has experience with technology transfer, intellectual property, clinical development plans, small business innovative research grants, product development, medical device quality systems, good clinical practice, 510K FDA medical device regulations, medical affairs, clinical trial design and management.
Dr. Jackson’s conflict of interest is his employment. MacuLogix is the manufacturer of the AdaptDx, a dark adaptometer.